Education
About Us
Working with TipRanks
Follow Us
TELA Bio (TELA)
NASDAQ:TELA
Total Valuation
TELA Bio has a market cap or net worth of $76.34M. The enterprise value is $184.98M.
Market Cap$76.34M
Enterprise Value$184.98M
Share Statistics
TELA Bio has 39,554,990 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,554,990
Owned by Insiders19.23%
Owned by Institutions50.39%
Financial Efficiency
TELA Bio’s return on equity (ROE) is -1.33 and return on invested capital (ROIC) is -47.52%.
Return on Equity (ROE)-1.33
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-47.52%
Return on Capital Employed (ROCE)-0.48
Revenue Per Employee331.58K
Profits Per Employee-181.06K
Employee Count209
Asset Turnover0.80
Inventory Turnover1.78
Valuation Ratios
The current PE Ratio of TELA Bio is -2.28. TELA Bio’s PEG ratio is -0.44.
PE Ratio-2.28
PS Ratio0.00
PB Ratio13.08
Price to Fair Value3.03
Price to FCF-4.39
Price to Operating Cash Flow-4.59
PEG Ratio-0.44
Income Statement
In the last 12 months, TELA Bio had revenue of 69.30M and earned -37.84M in profits. Earnings per share was -1.33.
Revenue69.30M
Gross Profit46.49M
Operating Income-34.12M
Pretax Income-37.98M
Net Income-37.84M
EBITDA-31.68M
Earnings Per Share (EPS)-1.33
Cash Flow
In the last 12 months, operating cash flow was -36.94M and capital expenditures -717.00K, giving a free cash flow of -37.65M billion.
Operating Cash Flow-36.94M
Free Cash Flow-37.65M
Free Cash Flow per Share-0.95
Dividends & Yields
TELA Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change-59.08%
50-Day Moving Average1.47
200-Day Moving Average2.21
Relative Strength Index (RSI)60.28
Average Volume (3m)135.92K
Important Dates
TELA Bio upcoming earnings date is Aug 6, 2025, Before Open (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
TELA Bio as a current ratio of 5.01, with Debt / Equity ratio of 279.04%
Current Ratio5.01
Quick Ratio4.19
Debt to Market Cap0.48
Net Debt to EBITDA0.35
Interest Coverage Ratio-6.45
Taxes
In the past 12 months, TELA Bio has paid -144.00K in taxes.
Income Tax-144.00K
Effective Tax Rate<0.01
Enterprise Valuation
TELA Bio EV to EBITDA ratio is -2.37, with an EV/FCF ratio of -1.76.
EV to Sales1.08
EV to EBITDA-2.37
EV to Free Cash Flow-1.76
EV to Operating Cash Flow-1.81
Balance Sheet
TELA Bio has $42.83M in cash and marketable securities with $41.81M in debt, giving a net cash position of -$1.03M billion.
Cash & Marketable Securities$42.83M
Total Debt$41.81M
Net Cash-$1.03M
Net Cash Per Share-$0.03
Tangible Book Value Per Share$0.94
Margins
Gross margin is 65.30%, with operating margin of -49.23%, and net profit margin of -54.60%.
Gross Margin65.30%
Operating Margin-49.23%
Pretax Margin-54.81%
Net Profit Margin-54.60%
EBITDA Margin-45.72%
EBIT Margin-47.18%
Analyst Forecast
The average price target for TELA Bio is $3.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.17
Price Target Upside61.73% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast12.78%
EPS Growth Forecast15.53%